Share Twitter LinkedIn Facebook Email Professor Peter Schmid, MD, Ph.D. from Bart’s Cancer Institute, Queen Mary University of London speaks about SABCS 2021 Review of the Year – Advanced Breast Cancer.
2025 Breast Cancer Updates: Dr. Evanthia Roussos Torres on Biomarkers, Immunotherapy, and the Future of Treatment – MOASC Breast 6 Mins Read
FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer Breast 2 Mins Read